At1 receptors mediate angiotensin II uptake and transport by bovine brain microvessel endothelial cells in primary culture

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 1, 1999, Pages 30-35

  Rose, Jayna M ^a   Audus, Kenneth L ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Angiotensin II; Angiotensin receptor antagonists; Blood brain barrier; Brain microvessel endothelial cells; Losartan; PD 123,319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; GLYCOPROTEIN P; LOSARTAN; RHODAMINE 123; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HORMONE TRANSPORT; IMMUNOBLOTTING; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; ANIMAL; BRAIN; CAPILLARY; CELL CULTURE; CELL MEMBRANE PERMEABILITY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANGIOTENSIN II; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; CATTLE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; IMIDAZOLES; LOSARTAN; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 0032589840     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199901000-00005     Document Type: Article

References (37)

1. Reid JL, Rubin PC. Peptides and central neural regulation of the circulation. Physiol Rev 1987;67:725-49.
2. Paul M, Bader M, Steckelings UM, Voigtlander T, Ganten D. The renin-angiotensin system in the brain: localization and functional significance. Drug Res 1993;43:207-13.
3. Wright JW, Harding JW. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Rev 1992;17:227-62.
4. Phillips MI. Functions of angiotensin in the central nervous system. Annu Rev Physiol 1987;49:413-35.
5. Speth RC, Harik SI. Angiotensin II receptor binding sites in brain microvessels. Proc Natl Acad Sci USA 1985;82:6340-3.
6. Grammas P, Diglio C, Giacomelli F, Weiner J. Cerebrovascular angiotensin II receptors in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1989;13:227-32.
7. Grubb RLJ, Raichle ME. Intraventricular angiotensin II increases brain vascular permeability. Brain Res 1981;210:426-30.
8. Oztas B, Sandalci U. Reversibility of blood-brain barrier dysfunction in acute hypertension induced by angiotensin. Exp Neurol 1984;84:666-70.
9. Guillot FL, Audus KL. Some characteristics of specific angiotensin II binding sites on bovine brain microvessel endothelial cell monolayers. Peptides 1991;12:535-40.
10. Mineo C, Yagyu Y, Imanaka T, Takano T. Transcellular transport of angiotensin II through a cultured arterial endothelial monolayer. Exp Cell Res 1990;190:99-103.
11. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
12. Pardridge WM. Peptide drug delivery to the brain. New York: Raven Press, 1991.
13. Friden PM. Receptor-mediated transport of peptides and proteins across the blood-brain barrier. In: Pardridge WM, ed. The blood-brain barrier. New York: Raven Press, 1993:229-17.
14. Audus KL, Borchardt RT. Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm Res 1986;3:81-7.
15. Audus KL, Borchardt RT. Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers. J Neurochem 1986;47:484-8.
16. Audus KL, Borchardt RT. Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann NY Acad Sci 1987;507:9-18.
17. Baranczyk-Kuzma A, Audus KL, Borchardt RT. Catecholamine-metabolizing enzymes of bovine brain microvessel endothelial cell monolayers. J Neurochem 1986;46:1956-60.
18. Bowman PD, Ennis SR, Rarey KE, Betz AL, Goldstein GW. Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann Neurol 1983;14:396-402.
19. McKenzie FR. Basic techniques to study G-protein function. In: Milligan G, ed. Signal transduction: a practical approach. Oxford: IRL Press, 1992:33-4.
20. Rose JM, Audus KL. Cellular mechanisms regulating losartan transfer across brain capillary endothelial cells in primary culture. S T P Pharma Sci 1997;7:71-7.
21. Guillot FL, Audus KL. Angiotensin peptide regulation of fluid-phase endocytosis in brain microvessel endothelial cell monolayers. J Cerebr Blood Flow Metab 1990;10:827-34.
22. Stanimirovic D, Morley P, Ball R, Hamel E, Mealing G, Durkin JP. Angiotensin II-induced fluid phase endocytosis in human cerebrovascular endothelial cells is regulated by the inositol-phosphate signaling pathway. J Cell Physiol 1996;169:455-67.
23. Hegmann EJ, Bauer HC, Kerbel RS. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res 1992;52:6969-75.
24. Jette L, Murphy GF, LeClerc J, Beliveau R. Interaction of drugs with P-glycoprotein in brain capillaries. Biochem Pharmacol 1995; 50:1701-9.
25. Lautier D, Canitrot Y, Salmon JM. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. Anticancer Res 1994; 14:2589-96.
26. Wang Q, Yang H, Miller DW, Elmquist WF. Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem Biophys Res Commun 1995;211:719-26.
27. Smith RD, Chiu AT, Wong PC, Herblin WF, Timmermans PBMWM. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 1992;32:135-65.
28. Anderson JM, Wimalasena R, Foster K, Stobaugh JF, Audus KL. Internalization and transport of angiotensin II by bovine brain microvessel endothelial cells (BBMECs) [Abstract]. Pharm Res 1994;11:S-251.
29. Rose MJ, Lunte SM, Carlson RG, Stobaugh JF. Development of hydroquinone-based derivatization reagents for the quantitation of amines using electrochemical detection [Abstract]. Pharm Res 1995;12:5-38.
30. Rose JM, Audus KL. Angiotensin II transport in bovine brain microvessel endothelial cells. Peptides 1998;19:1023-30.
31. Barnes JM, Steward LJ, Barber PC, Barnes NM. Identification and characterisation of angiotensin II receptor subtypes in human brain. Eur J Pharmacol 1993;230:251-8.
32. 8)AII by cultured bovine adrenocortical cells. Endocrinology 1986;118:2312-8.
33. Griendling KK, Delafontaine P, Rittenhouse SE, Gimbrone MA, Alexander RW. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II - stimulated cultured vascular smooth muscle cells. J Biol Chem 1987;262:14555-62.
34. Ullian ME, Linas SL. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest 1989; 84:840-6.
35. Fukuta M, Okada K, Iinuma S, Yanai S, Toguchi H. Insulin fragments as a carrier for peptide delivery across the blood-brain barrier. Pharm Res 1994;11:1681-8.
36. Pardridge WM, Buciak JL, Friden PM. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther 1991;259:66-70.
37. Gimbrone MA, Alexander RW. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 1975;189:219-20.